Articles by Frank B. Gelder, PhD - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Frank B. Gelder, PhD

Frank B. Gelder, PhD


Frank B. Gelder, PhD, is founding scientist at Virionyx Corporation Ltd.

The Therapeutic Vaccine Potential of MIS416 Adjuvant
January 2, 2009

This article discusses the potential of MIS416 adjuvant, a vaccine adjuvant and immunogen co-delivery system, to provide adequate immunostimulation to overcome host factors that may limit the success of therapeutic vaccines.

ADVERTISEMENT

ADVERTISEMENT

Click here